Successful treatment of mixed-type autoimmune hemolytic anemia with rituximab in a child following liver transplantation.
Development of a severe form of mixed-type AIHA after orthotopic liver transplantation is a rare, but a life-threatening event. We report a case of mixed-type AIHA that developed in a child after hepatocyte and living-related orthotopic liver transplantation for factor VII deficiency.
Haller
Wolfram
W
Paediatric Liver Centre, King's College Hospital NHS Foundation Trust, Denmark Hill, London, UK. wolframhaller@nhs.net
Hind
Jonathan
J
Height
Sue
S
Mitry
Ragai
R
Dhawan
Anil
A
D000744:Anemia, Hemolytic, Autoimmune / Q000188:drug therapy*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D007223:Infant; D016031:Liver Transplantation; D008297:Male; D011183:Postoperative Complications / Q000188:drug therapy*; D000069283:Rituximab
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D007155:Immunologic Factors; D000069283:Rituximab